REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 102 filers reported holding REGULUS THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q2 2018 | $10,000 | -37.5% | 15,000 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $16,000 | 0.0% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $16,000 | -15.8% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $19,000 | +26.7% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $15,000 | -6.2% | 15,000 | +50.0% | 0.00% | 0.0% |
| Q1 2017 | $16,000 | -27.3% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $22,000 | -33.3% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $33,000 | +13.8% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $29,000 | -68.8% | 10,000 | -6.6% | 0.00% | -66.7% |
| Q4 2015 | $93,000 | – | 10,705 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 327,350 | $943,000 | 0.99% |
| DAFNA Capital Management LLC | 421,500 | $1,218,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 350,000 | $1,012,000 | 0.18% |
| BOURGEON CAPITAL MANAGEMENT LLC | 70,704 | $204,000 | 0.13% |
| Piermont Capital Management Inc. | 151,924 | $439,000 | 0.11% |
| Virtus ETF Advisers LLC | 46,269 | $134,000 | 0.10% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 389,144 | $1,124,000 | 0.08% |
| GLOBEFLEX CAPITAL L P | 80,637 | $233,000 | 0.06% |
| South Dakota Investment Council | 900,000 | $2,601,000 | 0.06% |
| FOX RUN MANAGEMENT, L.L.C. | 33,100 | $96,000 | 0.05% |